This Is What A Nation Cut Off From The Rest Of The World Looks Like
Getting Harder to Spell T-R-A-D-E Without An ‘L’
USD/CHF Rises As SNB, Others Wind Down Dollar Liquidity Operations
Week Ahead – Jackson Hole Goes Virtual
Seth Klarman: The current economic situation Is Surreal
Futures Tumble, Dollar Soars After European PMIs Slump, Putting Recovery In Doubt
Criticism of Concentrated Index Risk Are Off Base
Macro Briefing | 21 August 2020
AstraZeneca’s Imfinzi Wins Japan Approval For Small Cell Lung Cancer
Swiss Watch Exports Tumble In July As Pandemic Slump Eases
FDA Approves New Kyprolis Combination Regimen
ESG Investment Filters – We Must Clean the Lens to Maintain Forward Momentum
2020 U.S. Election Primer
Global Stocks Slide After Fed Minutes Disappoint
Tokyo-based collaboration platform BeaTrust lands $2.8 million seed round
Why Beijing's Wolf Warrior Diplomacy Suddenly Quieted Down
BofA Puts Cost Of Re-Shoring At $1 Trillion
VanEck’s gaming & eSports ETF wins big in debut season
Blackstone Set To Win Bid For Takeda’s Consumer Health Unit - Report
Futures At All Time High As Target Reports Record Quarter
Bond Bull Lacy Hunt Warns Of A Huge Monetary Risk
Macro Briefing | 19 August 2020
What moments of uncertainty mean for war – and peace – between global rivals
The dollar has left the building
These 2 Beaten-Down Stocks Are Poised to Bounce Back, Say Analysts
AstraZeneca is changing up dosing regimens of its checkpoint player in the face of the pandemic. The FDA appears ready to make a quick assist
Futures Inch To Record High After Walmart Earnings Smash Expectations; Dollar Hits 2 Year Low
South China Sea: after all its posturing, the US is struggling to build a coalition against China
AstraZeneca Gets FDA Priority Review For New Dose Of Imfinzi Cancer Drug
AZ aims to cut cancer clinic visits with new Imfinzi regimen